NGM313

BIOLOGICAL2 trials

Sponsors

NGM Biopharmaceuticals, Inc

Conditions

ObeseObesity

Phase 1

Phase 1 Study of NGM313 in Healthy Adult Participants

CompletedNCT02708576

NGM Biopharmaceuticals, IncObesity

Start: 2016-02-29End: 2017-04-30Updated: 2017-09-14

Study of NGM313 in Obese Participants

CompletedNCT03298464

NGM Biopharmaceuticals, IncObese

Start: 2017-09-11End: 2018-07-17Updated: 2019-03-13